4D Molecular Therapeutics, Inc. (FDMT) Reports FY Loss of $2.58
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported FY EPS of ($2.58).
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported FY EPS of ($2.58).
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.